Ellington Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,400
| Closed | -$279K | – | 586 |
|
|
2019
Q3 | $279K | Buy |
+4,400
| New | +$279K | 0.05% | 373 |
|
|
2019
Q2 | – | Sell |
-4,500
| Closed | -$293K | – | 631 |
|
|
2019
Q1 | $293K | Sell |
4,500
-1,500
| -25% | -$97.7K | 0.05% | 345 |
|
|
2018
Q4 | $375K | Buy |
6,000
+2,700
| +82% | +$169K | 0.11% | 181 |
|
|
2018
Q3 | $255K | Sell |
3,300
-8,200
| -71% | -$634K | 0.07% | 370 |
|
|
2018
Q2 | $815K | Buy |
+11,500
| New | +$815K | 0.06% | 87 |
|
|
2018
Q1 | – | Sell |
-5,900
| Closed | -$423K | – | 881 |
|
|
2017
Q4 | $423K | Sell |
5,900
-1,700
| -22% | -$122K | 0.07% | 251 |
|
|
2017
Q3 | $616K | Sell |
7,600
-2,100
| -22% | -$170K | 0.11% | 145 |
|
|
2017
Q2 | $687K | Buy |
9,700
+5,200
| +116% | +$368K | 0.1% | 153 |
|
|
2017
Q1 | $306K | Sell |
4,500
-1,800
| -29% | -$122K | 0.01% | 451 |
|
|
2016
Q4 | $451K | Sell |
6,300
-1,100
| -15% | -$78.7K | 0.07% | 222 |
|
|
2016
Q3 | $585K | Buy |
+7,400
| New | +$585K | 0.16% | 222 |
|
|
2015
Q4 | – | Sell |
-3,000
| Closed | -$295K | – | 673 |
|
|
2015
Q3 | $295K | Sell |
3,000
-6,900
| -70% | -$679K | 0.08% | 417 |
|
|
2015
Q2 | $1.16M | Buy |
9,900
+3,300
| +50% | +$386K | 0.28% | 77 |
|
|
2015
Q1 | $648K | Buy |
6,600
+500
| +8% | +$49.1K | 0.13% | 209 |
|
|
2014
Q4 | $575K | Buy |
6,100
+1,100
| +22% | +$104K | 0.19% | 150 |
|
|
2014
Q3 | $532K | Sell |
5,000
-1,400
| -22% | -$149K | 0.37% | 37 |
|
|
2014
Q2 | $531K | Hold |
6,400
| – | – | 0.25% | 104 |
|
|
2014
Q1 | $454K | Buy |
6,400
+1,900
| +42% | +$135K | 0.13% | 240 |
|
|
2013
Q4 | $338K | Sell |
4,500
-2,900
| -39% | -$218K | 0.12% | 279 |
|
|
2013
Q3 | $465K | Sell |
7,400
-700
| -9% | -$44K | 0.09% | 344 |
|
|
2013
Q2 | $415K | Buy |
+8,100
| New | +$415K | 0.08% | 388 |
|